首页> 美国卫生研究院文献>other >Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy

【2h】

Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy

机译：短期中度或大剂量瑞舒伐他汀预防造影剂肾病的功效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:The prophylactic efficacy of statin pretreatment for the prevention of contrast-induced nephropathy (CIN) in patients undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI) remains controversial. The aim of the study was to perform a meta-analysis of randomized controlled trials (RCTs) to assess the effectiveness of short-term moderate or high-dose rosuvastatin pretreatment in preventing CIN.

机译：背景：他汀类药物预处理对冠状动脉造影（CAG）或经皮冠状动脉介入治疗（PCI）的患者所致的对比剂诱发的肾病（CIN）的预防作用仍然存在争议。该研究的目的是对随机对照试验（RCT）进行荟萃分析，以评估短期中度或大剂量瑞舒伐他汀预处理在预防CIN中的有效性。

著录项

期刊名称 other
作者
Min Liang; Shicheng Yang; Naikuan Fu;
展开▼
作者单位

展开▼
年(卷),期 -1(96),27
年度 -1
页码 e7384
总页数 12
原文格式 PDF
正文语种
中图分类
关键词
contrast-induced nephropathy coronary angiography percutaneous coronary intervention rosuvastatin;

机译：造影剂肾病;冠状动脉造影;经皮冠状动脉介入治疗;瑞舒伐他汀;

相似文献

外文文献
中文文献
专利

1. Relationship Between Inflammation and Benefits of Early High-Dose Rosuvastatin on Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome The Pathophysiological Link in the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention) [J] . Toso Anna, Leoncini Mario, Maioli Mauro, JACC. Cardiovascular interventions . 2014 ,第12期

机译：急性冠状动脉综合征患者炎症与早期大剂量瑞舒伐他汀对造影剂引起的肾病的益处之间的关系PRATO-ACS研究的病理生理联系（瑞舒伐他汀和抗血小板治疗对造影剂引起的肾病和心肌损害的保护作用接受冠状动脉介入治疗的急性冠状动脉综合征
2. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS study (protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome) [J] . LeonciniM., TosoA., MaioliM., Journal of the American College of Cardiology . 2014 ,第1期

机译：早期大剂量瑞舒伐他汀在急性冠脉综合征中预防对比剂引起的肾病：PRATO-ACS研究的结果（瑞舒伐他汀和抗血小板治疗对对比剂诱发的急性冠脉综合征急性肾损伤和心肌损伤的保护作用）
3. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN (atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy) trial. [J] . Patti G, Ricottini E, Nusca A, The American Journal of Cardiology . 2011 ,第1期

机译：短期，大剂量阿托伐他汀预处理可预防接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者的造影剂诱发的肾病（来自ARMYDA-CIN（阿托伐他汀用于减少血管成形术-造影剂诱发的肾病期间的心肌损伤）试验）。
4. The use of statistical analysis methods in assessing long-term prognoses in patients with acute coronary syndrome and contrast-induced nephropathy [C] . N Kobzeva, V Terentev, I Zolotuhina International Scientific-Technical Conference "Dynamics of Technical Systems" . 2020

机译：统计分析方法在评估急性冠状动脉综合征和对比肾病患者中的长期预期
5. Pyrazinoylguanidine attenuates diabetic nephropathy and prevents cataractogenesis in STZ-diabetic rats. [D] . Follansbee, Mark Howard. 1997

机译：吡嗪酰基胍可减轻糖尿病性肾病，并预防STZ糖尿病大鼠的白内障发生。
6. Efficacy of short-term moderate or high-dose statin therapy for the prevention of contrast-induced nephropathy in high-risk patients with chronic kidney disease: systematic review and meta-analysis [O] . Yan-Lin Zhou, Li-Qun Chen, Xiao-Gang Du 2021

机译：短期中等或高剂量毒素治疗在高危肾病患者中预防对比引起的肾病疗效的疗效：系统评价和荟萃分析
7. Faculty Opinions recommendation of Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials. [O] . Eric Hoste 2019

机译：教师意见提出短期中度或高剂量罗苏伐他汀在预防造影肾病中的疗效的推荐：15种随机对照试验的META分析。

Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy

摘要

著录项

相似文献

相关主题

期刊订阅